Radioiodine and thyroid-associated ophthalmopathy

Orbit

Volumn 15, Issue 3, 1996, Pages 197-203

  Marcocci, Claudio ^a   Bartalena, Luigi ^a   Bogazzi, Fausto ^a   Bruno Bossio, Gabriella ^a   Tanda, Maria Laura ^a   Manetti, Luca ^a   Dell'Unto, Enrica ^a   Pinchera, Aldo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Radioiodine; Thyroid associated ophthalmopathy

Indexed keywords

GLUCOCORTICOID; RADIOACTIVE IODINE;

ENDOCRINE OPHTHALMOPATHY; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; REVIEW;

EID: 0029786958     PISSN: 01676830     EISSN: None     Source Type: Journal    
DOI: 10.3109/01676839609150237     Document Type: Review

References (26)

1. Burch HB, Wartofsky L Hyperthyroidism. In: Bardin CW (editor). Current Therapy in Endocrinology and Metabolism. St Louis: Mosby, 1994; 64-70.
2. Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Pinchera A. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism. Thyroid 1992; 2:171-178.
3. Burch HB, Wartofsky L. Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr Rev 1993; 14:747-793.
4. Werner SC, Coelho B, Quimby EH. Ten year results of I-131 therapy of hyperthyroidism. Bull NY Acad Med 1957; 33:783-806.
5. Hamilton HE, Schultz RO, De Gowin EL. The endocrine eye lesion in hyperthyroidism. Arch Intern Med 1960; 105:675-685.
6. Kriss JP, Pleshakov V, Rosenblum AL, Holderness M, Sharp G, Utiger R. Studies on the pathogenesis of ophthalmopathy of Graves' disease. J Clin Endocrinol Metabol 1967; 27:582-593-
7. Pequegnat EP, Mayberry WE, McConahey WM, Wyse EP. Large doses of radioiodine in Graves' disease: Effect on ophthalmopathy and long-acting thyroid stimulator. Mayo Clin Proc 1967; 42:802-811.
8. Hamilton RD, Mayberry WE, McConahey WM, Hanson KC. Ophthalmopathy of Graves' disease: A comparison between patients treated surgically and patients treated with radioiodine. Mayo Clin Proc 1967; 42:812-818.
9. Hetzel BS, Mason EK, Kwan WH. Studies of serum long-acting thyroid stimulator (LATS) in relation to exophthalmos after therapy for thyrotoxicosis. Austra Ann Med 1967; 17:307-311.
10. Aron-Rosa D, Pérez R, Abitbol Y. Malignant exophthalmos after iodine-131 treatment. Mod Probl Ophthalmol 1973; 14:432-434.
11. Calissendorf BM, Soderstrom M, Alveryd A. Ophthalmopathy and hyperthyroidism. A comparison between patients receiving different antithyroid treatments. Acta Ophthalmol 1986; 64:698-703.
12. Sridama V, DeGroot LJ. Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 1989; 87:70-73.
13. Vestergaard H, Laurberg P. Radioiodine and aggravation of Graves' ophthalmopathy. Lancet 1989; 2:47.
14. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989; 321:1349-1352.
15. Barth A, Probst P, Burgi H. Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine. J Endocrinol Invest 1991; 14:209-212.
16. Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren JG, Blonigren H, Taube A, and The Thyroid Study Group. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 1992; 326:1733-1738.
17. Fernandez-Sanchez JR, Rosell Pradas J, Carazo Martinez O. Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy. Br J Surg 1993; 80:1134-1136.
18. Marcocci C, Bartalena L, Bogazzi F, Panicucci M, Pinchera A. Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol (Copenh) 1989; 120:473-478.
19. Bartalena L, Martino E, Marcocci C, Bogazzi F, Panicucci M, Velluzzi F, et al. More on smoking habits and Graves' ophthalmopathy. J Endocrinol Invest 1989; 12:733-737.
20. Tallsted L, Lundell G, Blomgren H, Bring J. Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 1994; 130:494-497.
21. Gorman CA. Radioiodine therapy does not aggravate Graves' ophthalmopathy. In: De Groot LJ, Gorman CA, Pinchera A, Bartalena L, Marcocci C, Wiersinga WM, Prummel MF, Wartofsky L. Therapeutic Controversies: Radiation and Graves' ophthalmopathy. J Clin Endocrinol Metabol 1995; 80:340-342.
22. Bauer FK, Catz B. Radioactive iodine therapy for progressive malignant exophthalmos. Acta Endocrinol (Copenh) 1966; 51:15-22.
23. Bartalena L, Marcocci C, Chiovato L, Laddaga M, Lepri G, Andreasni D, et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: Comparison with systemic corticosteroids alone. J Clin Endocrinol Metabol 1983; 56:1139-1144.
24. Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Lepri A, Pinchera A. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: Results of a prospective study. J Endocrinol Invest 1991; 14:853-860.
25. Pinchera A, Liberti P, Martino E, Fenzi GF, Grasso L, Rovis L, et al. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. J Clin Endocrinol Metabol 1969; 29:231-238.
26. Gamstedt A, Karlsson A. Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: Thyroid autoantibody responses and outcome of therapy. J Clin Endocrinol Metabol 1991; 73:125-131.